Resources

More than 150 leading global health and development thinkers convened on June 15, 2016, for The Innovation Effect: Powering Disruptive Global Health Solutions in Washington, DC. This conference report provides an overview of the insights shared when attendees explored what happens when unique partnerships, disruptive technologies, transformed systems, and data-driven insights combine in often unexpected ways to create dramatic improvements in the health and well-being of people around the world.

This case study details Nepal’s successful efforts—despite several challenges—against Japanese encephalitis (JE), from establishing disease surveillance to a robust routine JE immunization program.

The messages within this document can be used by advocates, program implementers, and others who seek to promote increased access to and availability of affordable, quality-assured medicines, technologies and other health supplies for reproductive, maternal, newborn, child and adolescent health.

PATH’s advocacy work builds on and continues global efforts to expand access to simple, essential, and affordable medicines, medical devices, and other health supplies to prevent deaths of women and children worldwide.

In 2014, PATH conducted interviews with stakeholders in Senegal and Uganda to assess receptivity to self-injection of the contraceptive, subcutaneous DMPA (DMPA-SC, brand name Sayana Press) as well as the evidence requirements and processes necessary to chart a course for adoption, introduction, and scale-up of self-injection as a service-delivery practice in the two countries. For more information, email FPoptions@path.org or visit www.path.org/dmpa-sc.